Treatment with rosuvastatin for severe dyslipidaemia in patients with schizophrenia and Schizoaffective disorder

被引：0
|
作者：
De Hert, M.
Kalnicka, D.
van Winkel, R.
Wampers, M.
Hanssens, L.
Van Eyck, D.
Scheen, A.
Peuskens, J.
机构：
[1] Katholieke Univ Leuven, Ctr Psychiat, Kortenberg, Belgium
[2] Charles Univ Prague, Dept Psychiat, Med Fac Hradec, Kralove, Czech Republic
[3] Univ Liege, Dept Epidemiol & Publ Hlth, Liege, Belgium
[4] Univ Liege, Dept Diabet Nutr & Metab Disorders, CHU Sart Tilman, Liege, Belgium
来源：
DRUG SAFETY | 2006年 / 29卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
178
引用
收藏
页码：1002 / 1002
页数：1
相关论文
共 50 条
  • [1] Treatment with rosuvastatin for severe dyslipidaemia in patients with schizophrenia and schizoaffective disorder
    De Hert, M. A.
    van Winkel, R.
    Wampers, M.
    Van Eyck, D.
    Hanssens, L.
    Scheen, A.
    Peuskens, J.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 498 - 498
  • [2] Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorder
    De Hert, Marc
    Kalnicka, Dita
    van Winkel, Ruud
    Wampers, Martien
    Hanssens, Linda
    Van Eyck, Dominique
    Scheen, Andre
    Peuskens, Joseph
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (12) : 1889 - 1896
  • [3] Pharmacological treatment of severe dyslipidaemia in patients with schizophrenia
    Hanssens, Linda
    De Hert, Marc
    Kalnicka, Dita
    van Winkel, Ruud
    Wampers, Martien
    Van Eyck, Dominique
    Scheen, Andre
    Peuskens, Joseph
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (01) : 43 - 49
  • [4] Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorder
    Lambert, M.
    Huber, C. G.
    Naber, D.
    Schacht, A.
    Wagner, T. T.
    Hundemer, H. -P.
    Karow, A.
    Schimmelmann, B. G.
    PHARMACOPSYCHIATRY, 2008, 41 (05) : 182 - 189
  • [5] Treatment response and gender in patients with schizophrenia and schizoaffective disorder
    Howard, CH
    Fiedosewicz, H
    Patel, C
    Klegon, DA
    Bayog, R
    Berman, I
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 232 - 232
  • [6] Psychopharmacological treatment of patients with schizoaffective disorder in comparison to schizophrenia and bipolar disorder
    Assion, H. J.
    Schweppe, A.
    Skiba, M.
    Juckel, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S321 - S322
  • [7] Risperidone versus olanzapine in the treatment of patients with schizophrenia or schizoaffective disorder
    Brecher, M
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 271 - 271
  • [8] Treatment Patterns for Schizoaffective Disorder and Schizophrenia Among Medicaid Patients
    Olfson, Mark
    Marcus, Steven C.
    Wan, George J.
    PSYCHIATRIC SERVICES, 2009, 60 (02) : 210 - 216
  • [9] Treatment of schizoaffective disorder and schizophrenia with mood symptoms
    Levinson, DF
    Umapathy, C
    Musthaq, M
    AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (08): : 1138 - 1148
  • [10] Ziprasidone: zealous in the treatment of schizophrenia and schizoaffective disorder
    Drugs & Therapy Perspectives, 2003, 19 (4) : 1 - 4
12345